{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:51:08Z","timestamp":1792518668289,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2015.03.002","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T17:36:19Z","timestamp":1428255379000},"page":"2289-2296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Nanoemulsion-based mucosal adjuvant induces apoptosis in human epithelial cells"],"prefix":"10.1016","volume":"33","author":[{"given":"Beata U.","family":"Orzechowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta F.","family":"Kukowska-Latallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa D.","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Gamian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Myc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.vaccine.2015.03.002_bib0205","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1177\/0961203309345724","article-title":"Adjuvants and autoimmunity","volume":"18","author":"Israeli","year":"2009","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.vaccine.2015.03.002_bib0210","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/jps.23039","article-title":"The role of adjuvant in mediating antigen structure and stability","volume":"101","author":"Braun","year":"2012","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2015.03.002_bib0215","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/14760584.6.5.723","article-title":"GlaxoSmithKline Adjuvant systems in vaccines: concepts, achievements and perspectives","volume":"6","author":"Garcon","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.03.002_bib0220","doi-asserted-by":"crossref","first-page":"C25","DOI":"10.1016\/j.vaccine.2010.07.021","article-title":"Unmet needs in modern vaccinology: adjuvants to improve the immune response","volume":"28","author":"Leroux-Roels","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.03.002_bib0225","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018ASIA\u2019 \u2013 autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2015.03.002_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.10.004","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects","volume":"47","author":"Perricone","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2015.03.002_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.033","article-title":"Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants","volume":"50","author":"Ahmed","year":"2014","journal-title":"J Autoimmun"},{"issue":"8","key":"10.1016\/j.vaccine.2015.03.002_bib0240","doi-asserted-by":"crossref","first-page":"e2954","DOI":"10.1371\/journal.pone.0002954","article-title":"Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine","volume":"3","author":"Makidon","year":"2008","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.002_bib0245","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/CVI.00440-07","article-title":"A novel: killed-virus nasal vaccinia virus vaccine","volume":"15","author":"Bielinska","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2015.03.002_bib0250","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1128\/IAI.00070-07","article-title":"Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge","volume":"75","author":"Bielinska","year":"2007","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.002_bib0255","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/aid.2007.0148","article-title":"Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates","volume":"24","author":"Bielinska","year":"2008","journal-title":"AIDS Res Hum Retrovir"},{"issue":"7","key":"10.1016\/j.vaccine.2015.03.002_bib0260","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4161\/hv.6.7.11818","article-title":"Efficacy: immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model","volume":"6","author":"Hamouda","year":"2010","journal-title":"Hum Vaccin"},{"issue":"7","key":"10.1016\/j.vaccine.2015.03.002_bib0265","doi-asserted-by":"crossref","first-page":"e21823","DOI":"10.1371\/journal.pone.0021823","article-title":"A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease","volume":"6","author":"Lindell","year":"2011","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.002_bib0270","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00430-009-0137-2","article-title":"Induction of immune response to the 17kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine","volume":"199","author":"Makidon","year":"2010","journal-title":"Med Microbiol Immunol"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2015.03.002_bib0275","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1016\/S0264-410X(03)00381-5","article-title":"Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion","volume":"21","author":"Myc","year":"2003","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2015.03.002_bib0280","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1158\/1078-0432.CCR-09-2891","article-title":"Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway","volume":"16","author":"Zitvogel","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.002_bib0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1615\/CritRevImmunol.v30.i2.60","article-title":"Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant","volume":"30","author":"Bielinska","year":"2010","journal-title":"Crit Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.002_bib0290","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.vaccine.2011.10.094","article-title":"Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens","volume":"30","author":"Stanberry","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2015.03.002_bib0295","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.vaccine.2012.12.033","article-title":"Nanoemulsion nasal adjuvant W805EC induces dendritic cell engulfment of antigen-primed epithelial cells","volume":"31","author":"Myc","year":"2013","journal-title":"Vaccine"},{"issue":"6671","key":"10.1016\/j.vaccine.2015.03.002_bib0300","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/32183","article-title":"Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs","volume":"392","author":"Albert","year":"1998","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.vaccine.2015.03.002_bib0305","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/sj.cdd.4401286","article-title":"Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells","volume":"10","author":"Hirt","year":"2003","journal-title":"Cell Death Differ"},{"issue":"11","key":"10.1016\/j.vaccine.2015.03.002_bib0310","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/15200","article-title":"Natural adjuvants: endogenous activators of dendritic cells","volume":"5","author":"Gallucci","year":"1999","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.vaccine.2015.03.002_bib0315","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"8","key":"10.1016\/j.vaccine.2015.03.002_bib0320","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.4049\/jimmunol.0803989","article-title":"Induction of tumor cell apoptosis or necrosis by conditional expression of cell death proteins: analysis of cell death pathways and in vitro immune stimulatory potential","volume":"182","author":"Lohmann","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.03.002_bib0325","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1097-0320(20010501)44:1<65::AID-CYTO1083>3.0.CO;2-Q","article-title":"Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: a reconsideration of the specificity of the annexin V\/propidium iodide assay","volume":"44","author":"Lecoeur","year":"2001","journal-title":"Cytometry"},{"issue":"8","key":"10.1016\/j.vaccine.2015.03.002_bib0330","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1002\/eji.201142346","article-title":"Nanoemulsion mucosal adjuvant uniquely activates cytokine production be nasal ciliated epithelium and induces dendritic cells trafficking","volume":"42","author":"Makidon","year":"2012","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.03.002_bib0335","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/IAI.73.4.1907-1916.2005","article-title":"Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells","volume":"73","author":"Fink","year":"2005","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.002_bib0340","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0966-842X(00)01937-5","article-title":"Salmonella-induced cell death: apoptosis, necrosis or programmed cell death?","volume":"9","author":"Boise","year":"2001","journal-title":"Trends Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2015.03.002_bib0345","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1462-5822.2004.00451.x","article-title":"Salmonella-induced macrophage death: multiple mechanisms, different outcomes","volume":"6","author":"Hueffer","year":"2004","journal-title":"Cell Microbiol"},{"issue":"7364","key":"10.1016\/j.vaccine.2015.03.002_bib0350","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature10400","article-title":"Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis","volume":"477","author":"Gunther","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vaccine.2015.03.002_bib0355","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/emboj.2009.1","article-title":"Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death","volume":"28","author":"Panaretakis","year":"2009","journal-title":"EMBO J"},{"issue":"45","key":"10.1016\/j.vaccine.2015.03.002_bib0360","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1016\/j.vaccine.2007.08.064","article-title":"Enhanced antigen delivery via cell death induced by the vaccine adjuvants","volume":"25","author":"Yang","year":"2007","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2015.03.002_bib0365","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.vaccine.2003.10.036","article-title":"The apoptotic and necrotic effects of tomatine adjuvant","volume":"22","author":"Yang","year":"2004","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2015.03.002_bib0370","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.vaccine.2003.08.048","article-title":"Cell death induced by vaccine adjuvants containing surfactants","volume":"22","author":"Yang","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2015.03.002_bib0375","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.191.3.423","article-title":"Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells","volume":"191","author":"Sauter","year":"2000","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2015.03.002_bib0380","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.188.7.1359","article-title":"Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36: and cross-present antigens to cytotoxic T lymphocytes","volume":"188","author":"Albert","year":"1998","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.vaccine.2015.03.002_bib0385","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/rheumatology\/38.12.1177","article-title":"The role of apoptosis in systemic lupus erythematosus","volume":"38","author":"Salmon","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2015.03.002_bib0390","doi-asserted-by":"crossref","first-page":"819467","DOI":"10.1155\/2012\/819467","article-title":"Th17 response and inflammatory autoimmune diseases","volume":"2012","author":"Waite","year":"2012","journal-title":"Int J Inflam"},{"key":"10.1016\/j.vaccine.2015.03.002_bib0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/374769","article-title":"The role of T helper (TH) 17 cells as a double-edged sword in the interplay of infection and autoimmunity with a focus on xenobiotic-induced immunomodulation","volume":"2013","author":"Hemdan","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2015.03.002_bib0400","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1371\/journal.pbio.0020241","article-title":"Mouse models of human autoimmune diseases: essential tools that require the proper controls","volume":"2","author":"Morel","year":"2004","journal-title":"PLoS Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1500287X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1500287X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T22:58:13Z","timestamp":1537743493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1500287X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":40,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0264410X1500287X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoemulsion-based mucosal adjuvant induces apoptosis in human epithelial cells","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}